Streptococcus pneumoniae synergizes with nontypeable Haemophilus influenzae to induce inflammation via upregulating

Jae Hyang Lim1, Unhwan Ha, Akihiro Sakai

  • 1Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, NY 14642, USA. Jae-Hyang_Lim@urmc.rochester.edu

BMC Immunology
|July 31, 2008
PubMed
Abstract

Insights

Streptococcus pneumoniae and nontypeable Haemophilus influenzae synergistically upregulate Toll-like receptor 2 (TLR2) expression in the lung. This occurs via pneumolysin and involves TLR4-MyD88-NF-kappaB signaling, with CYLD acting as a negative regulator.

Area of Science:

  • Immunology
  • Microbiology
  • Molecular Biology

Background:

  • Toll-like receptor 2 (TLR2) is crucial for immune responses to bacterial pathogens in the lung.
  • Streptococcus pneumoniae (S. pneumoniae) and nontypeable Haemophilus influenzae (NTHi) are known to synergize in inducing inflammation.
  • The synergistic effect of these bacteria on surface TLR2 expression remains unclear.

Purpose of the Study:

  • To investigate whether S. pneumoniae and NTHi synergistically upregulate TLR2 expression.
  • To identify the bacterial virulence factors and signaling pathways involved in this synergistic upregulation.
  • To explore the role of the tumor suppressor CYLD in regulating TLR2 expression during mixed bacterial infections.

Main Methods:

  • In vivo studies using mouse models of lung and middle ear infections.
  • Analysis of TLR2 expression levels following co-infection with S. pneumoniae and NTHi.
  • Investigation of signaling pathways including TLR4, MyD88, NF-kappaB, and the role of CYLD.

Main Results:

  • S. pneumoniae and NTHi synergistically upregulate TLR2 expression in mouse lung and middle ear.
  • Pneumolysin (PLY) from S. pneumoniae is a key virulence factor mediating this synergism.
  • S. pneumoniae PLY induces TLR2 expression through a TLR4-MyD88-NF-kappaB-dependent pathway.
  • Tumor suppressor CYLD negatively regulates S. pneumoniae-induced TLR2 upregulation via crosstalk with NF-kappaB signaling.

Conclusions:

  • This study provides direct evidence for synergistic TLR2 upregulation by S. pneumoniae and NTHi.
  • Novel insights into the molecular mechanisms regulating TLR2 expression in mixed bacterial infections are presented.
  • The findings highlight the complex interplay between bacterial virulence factors, host signaling pathways, and regulatory molecules in modulating immune responses.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...